Growth in biopharma and advanced treatments are enabling healthcare providers to take on previously untreatable diseases. This trend is resulting in better health outcomes, but also places additional demands on supply chain operations. From pre-clinical to commercial, there is a need for expanded cold chain networks, colder temperature regimes and higher service levels.
Our global cold chain network, express delivery and end-to-end monitoring capability make DHL a trusted partner to manage these changing demands. We specialize in getting your investigational medicinal product (IMP) out of the lab through to scaling to new commercial markets with precision and speed.
Discover Our Capabilities
Explore Solutions and Case Studies
DHL Life Sciences & Healthcare is committed to enabling you to address industry-specific challenges while driving growth and innovation, with a wide range of compliant solutions, including specialized white glove delivery with cryogenic temperature control, seamless IMP movement and end-to-end cold chain management for high-volume pharma.
Vital Signs: Symptoms of a Healthcare Sector in Transition
Take your White Glove and Cold Chain Services to the next level
Our latest report, ‘Delivering Next-Level Healthcare’ provides expert analysis on the technological, social and economic trends fuelling the current healthcare revolution. Learn all about the logistics and supply chain innovations that are now crucial to the future of healthcare.